Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Finasteride exposure harms tadpole reproduction and hormone balance.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Topical melatonin is a safe treatment that may reduce hair loss in people with androgenetic alopecia.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Flaxseed crackers can help reduce symptoms of PCOS in young women.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Androgens can both increase and decrease hair growth in different parts of the body.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.